---
figid: PMC4148120__oncotarget-05-5040-g007
figlink: /pmc/articles/PMC4148120/figure/F7/
number: Figure 7
caption: 'A: In absence of MEK inhibitor, BRAFV600E activation leads to the ERK1/2-dependent
  induction of SPRED genes, which block RAS signaling downstream of RTKs in melanoma
  cells. This results in low PI3K pathway activity. When cells are exposed to genotoxic
  stress, PUMA is induced and cells undergo apoptosis. B: Application of MEK inhibitor
  abolishes the expression of SPRED1 and SPRED2 and thereby relieves the negative
  feedback on RTK signaling. As a result, the PI3K pathway is activated. This prevents
  the induction of the apoptosis promoter PUMA in response to genotoxic stress and
  allows enhanced survival and protection from apoptosis.'
pmcid: PMC4148120
papertitle: The MAPK pathway as an apoptosis enhancer in melanoma.
reftext: Johannes M. Haydn, et al. Oncotarget. 2014 Jul;5(13):5040-5053.
pmc_ranked_result_index: '10542'
pathway_score: 0.9459209
filename: oncotarget-05-5040-g007.jpg
figtitle: MAPK pathway as an apoptosis enhancer in melanoma
year: '2014'
organisms: Homo sapiens
ndex: f2f41028-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4148120__oncotarget-05-5040-g007.html
  '@type': Dataset
  description: 'A: In absence of MEK inhibitor, BRAFV600E activation leads to the
    ERK1/2-dependent induction of SPRED genes, which block RAS signaling downstream
    of RTKs in melanoma cells. This results in low PI3K pathway activity. When cells
    are exposed to genotoxic stress, PUMA is induced and cells undergo apoptosis.
    B: Application of MEK inhibitor abolishes the expression of SPRED1 and SPRED2
    and thereby relieves the negative feedback on RTK signaling. As a result, the
    PI3K pathway is activated. This prevents the induction of the apoptosis promoter
    PUMA in response to genotoxic stress and allows enhanced survival and protection
    from apoptosis.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - PDK1
  - SPRED2
  - PIK3CB
  - PIK3CD
  - AKT1
  - PIK3CG
  - PIK3R6
  - BRAF
  - RAF1
  - MAPK1
  - MAP2K1
  - MAP2K2
  - NRAS
  - SPRED1
  - AKT3
  - MAPK3
  - KRAS
  - PIK3R3
  - HRAS
  - PIK3R4
  - PIK3CA
  - BBC3
  - PIK3R5
  - PD184352
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: SPRED1/2
  symbol: SPRED2
  source: hgnc_symbol
  hgnc_symbol: SPRED2
  entrez: '200734'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SPRED1/2
  symbol: SPRED1
  source: hgnc_symbol
  hgnc_symbol: SPRED1
  entrez: '161742'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PUMA
  symbol: PUMA
  source: hgnc_alias_symbol
  hgnc_symbol: BBC3
  entrez: '27113'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals:
- word: PD184352
  source: MESH
  identifier: C120227
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
